NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Sunday, March 21, 2010 7:23 PM

Henri Termeer

Type: Person

Name: Henri Termeer (Henri A Termeer)

First Reported Feb 28 2010 - Updated Feb 28 2010 - 2 Documents

Battle Brews for Control of Genzyme

The Burrill Report submits: In 2009, Genzyme stumbled as a viral contamination halted production at a key manufacturing plant, caused drug shortages for the company, and eventually financial disappointment to its investors. The missteps have left the ... [Published Feb 28 2010 by Seeking Alpha]

Entities: Genzyme, Henri Termeer, Biotechnology, TheStreet.com

First Reported Feb 24 2010 - Updated Feb 25 2010 - 2 Documents

Genzyme Corporation

BRIEF: Genzyme chief executive sells 100,000 shares

Genzyme Corp. disclosed today that Chairman and Chief Executive Henri Termeer has sold 100,000 shares of the embattled Cambridge-based drug maker.Termeer exercised options to buy the shares at $26.50 and sold them at $55.78 on Monday, turning a nice $2.9 ... [Published Feb 25 2010 by TradingMarkets]

Entities: Genzyme Corporation, Henri Termeer, Carl Icahn

First Reported Feb 24 2010 - Updated Feb 24 2010 - 1 Documents

Carl Icahn eyes Biotech leader Genzyme Corp

Pressure on Henri A. Termeer, chief executive of American biotechnology giant Genzyme Corporation (NASDAQ: GENZ), has been steadily mounting as the company’s... ... [Published Feb 24 2010 by HedgeTracker]

Entities: Genzyme Corporation, Carl Icahn, Biotechnology

First Reported Feb 23 2010 - Updated Feb 23 2010 - 3 Documents

Icahn aims to "fix" Genzyme, alludes to sale

By , MarketWatch BOBOSTON (MarketWatch) - One day after announcing he plans to nominate himself for the board of directors of Genzyme Corp., activist investor Carl Icahn said he aims to "fix" the ailing biotech company, which could include pushing for ... [Published Feb 23 2010 by MarketWatch]

Entities: Genzyme Corporation, Carl Icahn, Henri Termeer, Richard Mulligan, Denner

First Reported Feb 23 2010 - Updated Feb 23 2010 - 1 Documents

Carl Icahn

Showdown, Though Not Quite at the OK Corral

Carl Icahn is taking another swing at Genzyme; he is going after four seats on Genzyme’s nine-member board — for himself and for three associates, reports the New York Times. Icahn has not said what his plans might be for Genzyme, though the Times notes ... [Published Feb 23 2010 by GenomeWeb]

Entities: Genzyme, Carl Icahn, Henri Termeer

First Reported Feb 22 2010 - Updated Feb 23 2010 - 2 Documents

ImClone Systems Incorporated

Predatory Icahn moves in on weakened Genzyme

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major setbacks.The US company has been mired in problems ever since a viral contamination halted the manufacture of its biologic treatments Cerezyme ... [Published Feb 23 2010 by Pharmafocus]

Entities: Carl Icahn, Genzyme, Henri Termeer, ImClone Systems Incorporated

First Reported Feb 22 2010 - Updated Feb 23 2010 - 2 Documents

Icahn To Nominate Four Genzyme Directors

(EUNewsNet.com and OfficialWire)CAMBRIDGE, MAU.S. biotech corporation Genzyme said Monday activist investor Carl Icahn intends to nominate four directors to its nine-member board.Genzyme said it would "evaluate the nominees and make a recommendation that ... [Published Feb 23 2010 by OfficialWire]

Entities: Carl Icahn, Genzyme, Henri Termeer, Proxy Fight, Biotechnology

First Reported Feb 23 2010 - Updated Feb 23 2010 - 2 Documents

Genzyme Chief May Not Go Gently

While his legacy and tenure are under pressure from Carl C. Icahn, no one expects Genzyme chief Henri A. Termeer to go easily, The New York Times reports. ... [Published Feb 23 2010 by DealBook - NY Times]

Entities: Genzyme, Henri Termeer, Carl Icahn

First Reported Feb 22 2010 - Updated Feb 22 2010 - 8 Documents

Icahn Nominates Four To Genzyme Board (posted Today at 11:43am)

Worcester Business Journal Staff WriterTodayIcahn Partners LP has informed Cambridge-based Genzyme Corp. that it intends to seek four seats on the company's board of directors, including one for billionaire activist investor Carl Icahn.In a statement, ... [Published Feb 22 2010 by WBJournal.com]

Entities: Genzyme Corporation, Carl Icahn, Richard Mulligan, Icahn Partners LP

First Reported Feb 22 2010 - Updated Feb 22 2010 - 2 Documents

Genzyme in Icahn's Sights

CAMBRIDGE, Mass. (TheStreet) -- Carl Icahn is taking the fight to Genzyme(GENZ Quote) in a bid to wrest control of the biotech company from embattled Chairman and CEO Henri Termeer.The billionaire investor has formally notified Genzyme that he will seek ... [Published Feb 22 2010 by TheStreet.com]

Entities: Genzyme, Carl Icahn, Henri Termeer, Proxy Fight, Alex Denner

First Reported Feb 19 2010 - Updated Feb 19 2010 - 1 Documents

Genzyme earnings battered by manufacturing problems

Genzyme Corp’s fourth quarter profits have been savaged as a result of the supply problems its products have suffered, notably the Gaucher disease drug Cerezyme.Net income fell 73% to $23.2 million, reflecting the aftermath since June when the company's ... [Published Feb 19 2010 by Pharma Times]

Entities: Genzyme Corporation, Fabrazyme, Cerezyme

First Reported Feb 17 2010 - Updated Feb 18 2010 - 3 Documents

Genzyme Corporation Q4 2009 Earnings Call Transcript

Genzyme Corporation (GENZ)Q4 2009 Earnings Call TranscriptFebruary 17, 2010 11:00 am ETExecutivesPatrick Flanigan – Senior Director, IRHenri Termeer – Chairman, President and CEOMichael Wyzga – EVP, Finance and CFOJohn Butler – SVP, President, Cardiometabolic ... [Published Feb 18 2010 by Seeking Alpha]

Entities: Cerezyme, Fabrazyme, Henri Termeer, Cell Bank

Quotes

...Icahn," said Henri A Termeer, Genzyme's chairman and chief executive officer. "genzyme is regaining its momentum and will return to delivering sustainable growth this year. we have made significant changes to strengthen the company by investing in existing businesses, bringing in new senior leadership and improving corporate governance. we are completely focused on generating short and long-term value for shareholders."

Genzyme Gets Notice of Icahn Partners' Nomination of Directors [TradingMarkets - Feb 26 2010]

More Content

sort by: Date \| Relevance
Babson Holds World Stage Event to Celebrate and... [Zibb - Mar 11 2010]
6 Goals for Fixing Genzyme: Xconomy’s Q&A W... [SignOn San Diego - Mar 03 2010]
Battle Brews for Control of Genzyme [Seeking Alpha - Feb 28 2010]
Genzyme Gets Notice of Icahn Partners' Nominati... [TradingMarkets - Feb 26 2010]
Biotech Manufacturing Under Scrutiny [BioPharm International - Feb 25 2010]
BRIEF: Genzyme chief executive sells 100,000 sh... [TradingMarkets - Feb 25 2010]
Genzyme Corp. (GENZ) Chmn, President and CEO He... [Guru Focus - Feb 24 2010]
Icahn aims to "fix" Genzyme, alludes ... [MarketWatch - Feb 23 2010]
Showdown, Though Not Quite at the OK Corral [GenomeWeb - Feb 23 2010]
Predatory Icahn moves in on weakened Genzyme [Pharmafocus - Feb 23 2010]
Icahn To Nominate Four Genzyme Directors [OfficialWire - Feb 23 2010]
Genzyme Chief May Not Go Gently [New York Times - Feb 23 2010]
After Genzymes Stumbles, A Struggle for Its Con... [New York Times - Feb 23 2010]
Icahn Will Nominate Himself, Three Others To Ge... [FOXBusiness.com - Feb 22 2010]
Icahn Nominates Four To Genzyme Board (posted T... [WBJournal.com - Feb 22 2010]
Glaxo slides; XenoPort rebounds [MarketWatch - Feb 22 2010]
Genzyme Receives Notice From Carl Icahn Seeking... [RTTNews.com - Feb 22 2010]
Icahn Seeks To Shake-Up Genzyme's (GENZ) Board [Street Insider - Feb 22 2010]
Icahn Making His Move On Genzyme [Xconomy - Feb 22 2010]
Genzyme in Icahn's Sights [TheStreet.com - Feb 22 2010]
Carl Icahn makes his play for Genzyme board [Mass High Tech - Feb 22 2010]
Glaxo leads drug stocks lower on Avandia worries [MarketWatch - Feb 22 2010]
Biotech Stocks: Glaxo leads drug stocks lower o... [MarketWatch - Feb 22 2010]
Icahn Seeks Four Seats on Genzyme Board in Prox... [Moneynews - Feb 22 2010]
Genzyme faces proxy challenge from Icahn [Miami Herald - Feb 22 2010]
Icahn Wants to Join Genzyme’s Board, Bring Othe... [BusinessWeek - Feb 22 2010]
Report: Icahn to launch bid for Genzyme control [FierceBiotech - Feb 22 2010]
Icahn to nominate four to Genzyme's board [MarketWatch - Feb 22 2010]
Icahn Seeks 4 Seats on Genzyme Board [New York Times - Feb 22 2010]
UPDATE 1-Genzyme says Carl Icahn to nominate 4 ... [FinanzNachrichten.de - Feb 22 2010]

Blogs

sort by: Date \| Relevance
Battle Brews for Control of Genzyme [Biotech Sector and Stocks Analysis from Seeking ... - Feb 28 2010] The Burrill Report submits: In 2009, Genzyme stumbled as a viral contamination halted production at a key manufacturing plant, caused drug shortages for the company, ...
Carl Icahn eyes Biotech leader Genzyme Corp [HedgeTracker - Feb 24 2010] Pressure on Henri A. Termeer, chief executive of American biotechnology giant Genzyme Corporation (NASDAQ: GENZ), has been steadily mounting as the company’s... ...
Genzyme Chief May Not Go Gently [DealBook - NY Times - Feb 23 2010] While his legacy and tenure are under pressure from Carl C. Icahn, no one expects Genzyme chief Henri A. Termeer to go easily, The New York Times reports. ...
Genzyme Chief May Not Go Gently [DealBook - Feb 23 2010] While his legacy and tenure are under pressure from Carl C. Icahn, no one expects Genzyme chief Henri A. Termeer to go easily, The New York Times reports. ...
Happy new year, sort of [Pharma Blog Review - Jan 15 2010] Yes, the Pharma Blog Week in Review is back. I had to take a break from it over the holidays; I even became so silent on Twitter that I had a few folks ask me if ...